Russell Investments Group
CRSP icon

Russell Investments Group’s CRISPR Therapeutics CRSP Stock Holding History

Russell Investments Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.16M Buy
76,266
+28,818
+61% +$1.52M ﹤0.01% 1624
2026
Q1 		$2.26M Buy
47,448
+17,004
+56% +$897K ﹤0.01% 1816
2025
Q4 		$1.6M Sell
30,444
-11,589
-28% -$694K ﹤0.01% 1993
2025
Q3 		$2.72M Buy
+42,033
New +$2.41M ﹤0.01% 1694
2025
Q2 		– Sell
-60
Closed -$2.04K – 3861
2025
Q1 		$2.04K Buy
60
+10
+20% +$424 ﹤0.01% 3516
2024
Q4 		$1.97K Hold
50
– – ﹤0.01% 3447
2024
Q3 		$2.35K Sell
50
-200
-80% -$10.1K ﹤0.01% 3352
2024
Q2 		$13.5K Buy
+250
New +$14.5K ﹤0.01% 3016
2023
Q4 		– Sell
-1,590
Closed -$72.7K – 3226
2023
Q3 		$72.7K Hold
1,590
– – ﹤0.01% 2689
2023
Q2 		$90.7K Buy
1,590
+1,578
+13,150% +$89.5K ﹤0.01% 2625
2023
Q1 		$543 Buy
+12
New +$583 ﹤0.01% 3106
2022
Q2 		– Sell
-1,576
Closed -$98K – 2898
2022
Q1 		$98K Sell
1,576
-424
-21% -$26.6K ﹤0.01% 2566
2021
Q4 		$151K Sell
2,000
-1,900
-49% -$166K ﹤0.01% 2772
2021
Q3 		$436K Buy
+3,900
New +$490K ﹤0.01% 2523
2020
Q4 		– Sell
-633
Closed -$53K – 3064
2020
Q3 		$53K Sell
633
-875
-58% -$77.6K ﹤0.01% 3070
2020
Q2 		$113K Sell
1,508
-5,349
-78% -$313K ﹤0.01% 2860
2020
Q1 		$293K Buy
+6,857
New +$354K ﹤0.01% 2409
2018
Q1 		– Sell
-101,188
Closed -$2.15M – 2920
2017
Q4 		$2.15M Buy
+101,188
New +$1.92M ﹤0.01% 1779

Other funds holding CRSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Russell Investments Group's CRSP Position: Q2 2026 in Review

Russell Investments Group increased its CRISPR Therapeutics (CRSP) stake by 61% in Q2 2026, buying an estimated $1.52M and bringing the position to 76,266 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Russell Investments Group first reported a position in CRSP in Q4 2017 and has held it in 18 quarters since. 284 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Russell Investments Group held 76,266 shares of CRISPR Therapeutics worth $4.16M as of Q2 2026.
  • Russell Investments Group bought 28,818 CRISPR Therapeutics shares in Q2 2026, an estimated $1.52M.
  • CRISPR Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1624 holding.
  • Russell Investments Group first reported a position in CRISPR Therapeutics in Q4 2017 and has held it in 18 quarters since.
  • 284 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.